GOALS & OBJECTIVES
Prevention of Cardiovascular Disease with Aspirin Therapy: Is it for Everyone?
Activity Date: August 2003  — Activity Info: Volume3, (8B)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

GOAL
To provide healthcare professionals with current information regarding the benefits and risks of aspirin use for cardioprotection.

TARGET AUDIENCE
This activity is designed for physicians, pharmacists, and healthcare professionals who care for patients at risk for cardiovascular disease. No prerequisites required.

LEARNING OBJECTIVES
The Johns Hopkins University School of Medicine and the University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, participants should be able to:

  • Identify the cardioprotective benefits of aspirin therapy.
  • Review and analyze aspirin's effects in primary and secondary prevention of cardiovascular disease.
  • Evaluate the benefits versus the risks of aspirin therapy in different patient populations.
  • Discuss the role of aspirin in combination with other antithrombotic therapy.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.5 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

The estimated time to complete this educational activity: 0.5 hours.

Release date: August 15, 2003. Expiration date: August 15, 2005.

This program is approved for 0.5 hours (0.05 CEUs) and is cosponsored by the University of Tennessee College of Pharmacy, which is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. A statement of CE credit will be mailed within 4 weeks of successful completion and evaluation of the program. ACPE Program# 064-999-03-244-H01.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine and University of Tennessee College of Pharmacy names implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This program is supported by an unrestricted educational grant from Bayer HealthCare.

Advanced Studies in Medicine (ISSN-1530-3004) is published by Galen Publishing, a division of Advanced Studies in Medicine, an HMG Company. PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2003 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. Advanced Studies in Medicine is a registered trademark of The Healthcare Media Group, LLC.

     
Home | Contact Us | View Account | Need Help?